TGFB1 and Hepatic fibrosis: Many experimental data have shown that estradiol inhibits transforming growth factor (TGF)-β1 expression and hepatic stellate cell (HSC) activation, thereby suppressing the induction of hepatic fibrosis [8], [23], [24].